Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study

被引:7
|
作者
Matsuo, Koji [1 ,2 ]
Mandelbaum, Rachel S. [1 ]
Machida, Hiroko [3 ]
Yoshihara, Kosuke [4 ]
Matsuzaki, Shinya [1 ]
Klar, Maximilian [5 ]
Muggia, Franco M. [6 ]
Roman, Lynda D. [1 ,2 ]
Wright, Jason D. [7 ]
机构
[1] Univ Southern Calif, Dept Obstet & Gynecol, Div Gynecol Oncol, 2020 Zonal Ave,IRD 520, Los Angeles, CA 90033 USA
[2] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[3] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Hiratsuka, Kanagawa, Japan
[4] Niigata Univ, Sch Med, Dept Obstet & Gynecol, Niigata, Japan
[5] Univ Freiburg, Dept Obstet & Gynecol, Freiburg, Germany
[6] NYU, Dept Med, Div Med Oncol, 550 1St Ave, New York, NY 10016 USA
[7] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, New York, NY 10032 USA
关键词
Ovarian cancer; Breast cancer; Secondary cancer; Trend; Survival; MUTATION CARRIERS; RISK; IMPACT;
D O I
10.1007/s00404-020-05508-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose To examine trends, characteristics and outcomes of women who develop both ovarian and breast cancers. Methods This is a retrospective study examining the Surveillance, Epidemiology, and End Results Program from 1973 to 2013. Among ovarian cancer (n = 133,149) and breast cancer (n = 1,143,219) cohorts, women with both diagnoses were identified and temporal trends, tumor characteristics and survival were examined. Results There were 6446 women with both malignancies, representing 4.8% of the ovarian cancer cohort and 0.6% of the breast cancer cohort. Women with ovarian cancer who had secondary breast cancer were younger than those without secondary breast cancer early in the study period (52.3 versus 59.2 in 1973) but older in more recent years (68.5 versus 62.1 in 2013, P < 0.001). The number of breast cancer survivors who developed postcedent ovarian cancer decreased from 1.5 to 0.2% from 1979 to 2008 (relative risk reduction 90.0%, P < 0.05). Similarly, the number of ovarian cancer survivors who developed postcedent breast cancer decreased from 7.2 to 2.0% from 1973 to 2008 (relative risk reduction 72.4%, P < 0.05). Tumor characteristics were more likely to be favorable in women with ovarian cancer who developed postcedent breast cancer but unfavorable in those who had antecedent breast cancer (all, P < 0.05). Women with ovarian cancer who had secondary breast cancer had superior cause-specific survival compared to those who did not develop breast cancer regardless of breast cancer timing (P < 0.05). Conclusion Our study demonstrated that the demographics of women who develop breast cancer and ovarian cancer have changed over time and diagnosis of secondary breast cancer after ovarian cancer has decreased.
引用
收藏
页码:1235 / 1245
页数:11
相关论文
共 50 条
  • [21] Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study
    Huang, Chen-Yu
    Chang, Wen-Hsun
    Huang, Hsin-Yi
    Guo, Chao-Yu
    Chou, Yiing-Jenq
    Huang, Nicole
    Lee, Wen-Ling
    Wang, Peng-Hui
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 637 - 649
  • [22] Occupation and breast cancer risk among Shanghai women in a population-based cohort study
    Ji, Bu-Tian
    Blair, Aaron
    Shu, Xiao-Ou
    Chow, Wong-Ho
    Hauptmann, Michael
    Dosemeci, Mutafa
    Yang, Gong
    Lubin, Jay
    Gao, Yu-Tang
    Rothman, Nathaniel
    Zheng, Wei
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2008, 51 (02) : 100 - 110
  • [23] Cancer incidence, trends, and survival among immigrants to Sweden: a population-based study
    Mousavi, Seyed Mohsen
    Hemminki, Kari
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2015, 24 : S1 - S63
  • [24] Temporal trends in management and outcomes of testicular cancer: A population-based study
    Leveridge, Michael J.
    Siemens, D. Robert
    Brennan, Kelly
    Izard, Jason P.
    Karim, Safiya
    An, Howard
    Mackillop, William J.
    Booth, Christopher M.
    CANCER, 2018, 124 (13) : 2724 - 2732
  • [25] Fracture risk in women with breast cancer: A population-based study
    Melton, L. Joseph, III
    Hartmann, Lynn C.
    Achenbach, Sara J.
    Atkinson, Elizabeth J.
    Therneau, Terry M.
    Khosla, Sundeep
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (05) : 1196 - 1205
  • [26] Increased risk for familial ovarian cancer among Jewish women: A population-based case-control study
    Steinberg, KK
    Pernarelli, JM
    Marcus, M
    Khoury, MJ
    Schildkraut, JM
    Marchbanks, PA
    GENETIC EPIDEMIOLOGY, 1998, 15 (01) : 51 - 59
  • [27] Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility
    Rowley, Simone M.
    Mascarenhas, Lyon
    Devereux, Lisa
    Li, Na
    Amarasinghe, Kaushalya C.
    Zethoven, Magnus
    Lee, Jue Er Amanda
    Lewis, Alexandra
    Morgan, James A.
    Limb, Sharpe
    Young, Mary-Anne
    James, Paul A.
    Trainer, Alison H.
    Campbell, Ian G.
    GENETICS IN MEDICINE, 2019, 21 (04) : 913 - 922
  • [28] Impact of delayed treatment in women diagnosed with breast cancer: A population-based study
    Ho, Peh Joo
    Cook, Alex R.
    Ri, Nur Khaliesah Binte Mohamed
    Liu, Jenny
    Li, Jingmei
    Hartman, Mikael
    CANCER MEDICINE, 2020, 9 (07): : 2435 - 2444
  • [29] Historical trends of breast cancer burden attributable to metabolic factors among Chinese women, 1990-2019: A population-based epidemiological study
    Zhang, Liang-Zi
    Sun, Qi-Cheng
    Luan, Hang-Hang
    Yuan, Qian-Qian
    Deng, Tong
    Luo, Li-Sha
    Tan, Xiao-Lin
    THORACIC CANCER, 2024, 15 (16) : 1279 - 1286
  • [30] Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer - A population-based study
    Jordan, S.
    Steer, C.
    DeFazio, A.
    Quinn, M.
    Obermair, A.
    Friedlander, M.
    Francis, J.
    O'Brien, S.
    Goss, G.
    Wyld, D.
    Webb, P.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 310 - 317